As Of	Filer	Filing¹	For·On·As	Docs:Size	Issuer		Filing Agent

  4/3/24  Truex Samantha                    3          Director²   2:6K   Avalo Therapeutics, Inc.          Wyrick Robbins Y… LLP/FA 
  4/3/24  Kantoff Aaron                     3          Director²   2:6K   Avalo Therapeutics, Inc.          Wyrick Robbins Y… LLP/FA 
 3/28/24  Avalo Therapeutics, Inc.          DEFA14A                1:71K                                    Workiva Inc Wde… FA01/FA 
 3/28/24  Avalo Therapeutics, Inc.          8-K:1,2,3,5 3/27/24   19:5.8M                                   Workiva Inc Wde… FA01/FA 

____________
¹	Filing/Form Types:
	3	Initial Statement of Beneficial Ownership of Securities by an Insider — Form 3 { The Filer is an Insider² of the Issuer }.
	8-K	Current Report — Form 8-K { Item 1: Business & Operations;  2: Financial Info;  3: Securities & Trading;  4: Accountants & Accounting;  5: Governance & Management;  6: Asset-Backed Securities;  7: Disclosures;  8: Events;  9: Financials }.
	DEFA14A	Definitive Additional Proxy Soliciting Material — Schedule 14A.
²	Insider:  The Filer is a Director, Officer, 10% Owner and/or Other “insider” of the Issuer.